Drugs / Speedell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07583797 | Nov 2025 → Apr 2026 overdue | chemotherapy-induced neuropathy, diabetic polyneuropathy | SHIANG-SUO HUANG | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Speedell | “The "Speedell" hand and foot mask is a novel product formulated to act primarily as a TRPM8 activator.” NCT07583797 ↗ |
| Action | Activate | “formulated to act primarily as a TRPM8 activator” NCT07583797 ↗ |
| Route | Topical | “Daily topical application for 5 minutes over 7 days” NCT07583797 ↗ |
| Target | TRPM8 | “The "Speedell" hand and foot mask is a novel product formulated to act primarily as a TRPM8 activator.” NCT07583797 ↗ |